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1. Introduction 
Sanguinarine (fig. 1), a benzophenanthridine 
alkaloid, has been reported to possess anti-tumour 
and anti-microbial ctivity [ 1 ]. It inhibits both photo- 
synthetic phosphorylation associated with ferricyanide 
reduction and cyclic photophosphorylation catalyzed 
by phenazine methosulphate [2]. The alkaloid 
increases the intrinsic viscosity of DNA and uncouples 
respiration and oxidative phosphorylation in rat liver 
mitochondria [3]. These physical and biochemical 
effects can be attributed to the formation of a 
complex of sanguinarine with DNA. We report here a 
quantitative aspect of the binding of sanguinarine to 
calf thymus DNA from the measurements of absorp- 
tion spectrophotometry, equilibrium dialysis, melting 
behaviour, viscosity, circular dichroism and spectro- 
fluorimetric titration. We also compare our experi- 
mental data with ethidium bromide under identical 
experimental conditions and conclude that sangui- 
narine (like ethidium) binds by monofunctional mode 
of intercalation. 
2. Materials and methods 
Highly polymerized calf thymus DNA (type I) and 
ethidium bromide were purchased from Sigma 
Fig.1. Chemical structure of sanguinarine. 
(St Louis MO). Chemically pure sanguinarine chloride 
was kindly supplied by Dr S. B. Mahato of this Insti- 
tute. The concentrations of the DNA solutions are 
stated in terms of nucleotide phosphorus calculated 
from an extinction coefficient of 6600 M -1 . cm -1 at 
260 nm [4]. The drug concentrations were determined 
spectrophotometrically by using the following extinc- 
tion coefficients: ethidium, 5680 M -~ . cm -~ at 480 nm 
[5]; sanguinarine, 15 140 M -~ . cm -~ at 325 nm [6]. 
All binding experiments were conducted in 10 mM 
Tris-HC1 (pH 7.4) + 100 mM NaC1 (THS buffer) at 
22°C. For thermal melting experiments, 10 mM 
Tris-HC1 (pH 7.4) + 10 mM NaC1 (0.1 THS buffer) 
was used. Glass-distilled deionized water and analyt- 
ical grade reagents were used throughout. 
The absorption spectra of drugs mixed with or 
without DNA were obtained using the Zeiss automatic 
recording spectrophotometer 'Specord UV-Vis' 
against an appropriately prepared reference sample. 
Fluorescence measurements were recorded in an 
Aminco Bowman spectrophotofluorometer. The 
values of emission maxima reported here were taken 
from uncorrected emission spectra. Fluorescence 
titration of DNA with ethidium and sanguinarine was 
performed with the excitation 510 nm and 330 nm, 
respectively. The emission wavelengths were 610 nm 
and 420 nm, respectively. More detailed studies on 
the fluorescence of sanguinarine will be reported else- 
where. Spectrophotometric titration, equilibrium 
dialysis and spectrofluorimetric titration of the drug] 
DNA mixture were carried out following [4,5,7-10]. 
Thermal melting profiles were determined using a 
Zeiss spectrophotometer VSU 2 fitted with a thermo- 
static-controlled bath type U1 as in [4]. The visco- 
metric measurements of DNA were performed with a 
type 75 Cannon Manning semi-microviscometer at 
22 -+ 0.2°C. A quantitative analysis of the viscosi- 
metric measurements using various published proce- 
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dures or equations are described in section 3. The 
sheared DNA used for viscosimetric studies was 
prepared by using an MSE sonicator as in [4]. These 
gave calf thymus DNA with an intrinsic viscosity 0?o) 
of 2.1 dl/g from which the Mr-value was estimated to 
be ~3.5 × 10 s. Circular dichroism (CD) spectra were 
recorded in a JASCO spectropolarimeter model 
J-20 A with: ~ expansion, 10 nm/cm; time constant, 
16; scan speed, 2 cm/min; cell length, 10 mm). 
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3. Results 
The effect of progressive increasing concentration 
of DNA on the absorption spectra of sanguinarine is 
shown in fig.2. The spectral changes involved essen- 
tially a progressive r d shift and hypochromicity in
the complex until saturation was recorded at sangui- 
narine[DNA ratio of 0.16 (fig.2). A maximum red 
shift of  15 -17  nm was observed at a sanguinarine/ 
DNA ratio of 0.16 or lower. No significant change in 
the absorption pattern and, more particularly, no 
blue shift resulted at a very high value of sanguinarine/ 
Fig.3. Fluorescence spectra resulting from the interaction of 
(A) sanguinarine and (B) ethidium with calf thymus DNA: 
(A) curve (1) sanguinarine (32 ~tM) treated with varying con- 
centrations of DNA as shown by curves (2-6) denoting 29.7, 
59.5,149.1, 211.2 and 448 ~M DNA, respectively; (B) 
curve (1), ethidium (30 #M) is treated with varying concentra- 
tions of DNA as shown by curves 2-6 denoting 24, 55, 87, 
144 and 450 t~M DNA, respectively. 
DNA ratio. The drugs obeyed Beer's law in the con- 
centration range used. 
The strong enhancement of fluorescence spectra 
of ethidium with increasing concentration of DNA is 
shown in fig.3B. A different spectral distribution was 
found for sanguinarine-DNA complex. Fig.3A shows 
the progressive quenching effect of DNA on the 
fluorescence ofsanguinarine at 420 nm with increasing 
concentration of DNA. 
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Fig.2. Influence of calf thymus DNA on the absorption 
spectrum of sanguinarine inTHS buffer. Curve (1) sanguinarine 
(43/~M) treated with varying concentrations of DNA as 
shown by curves (2-9) denoting 10.1, 30.2, 50.3, 100.6, 
151.5,201.2, 301.8 and 430 uM DNA, respectively. 
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Fig.4. Scatchard plots for the binding of (A) sanguinarine and 
(B) ethidium to calf thymus DNA: r, ratio of tool ligand 
bound/mol nucleotides; C, the molar concentration f free 
ligand in solution; ( ) initial slope of binding isotherms; 
data points are shown for titration of calf thymus DNA by 
spectrophotometry (e,o) and spectrofluorimetry (A,z~). 
Sanguinarine and ethidium are 32 and 30 uM, respectively, 
in each experiment. 
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Table 1 
Fluorescence and equilibrium binding parameters of the interaction of DNA-sanguinarine 
and DNA-ethidium complexes 
Parameters Methods Sanguinarine Ethidium 
Free Bound Free Bound 
Absorption 
maxima (nm) 
Emission 
maxima (nm) 
Relative 
intensity 
k t (M -I) 
nt (no. binding 
sites/nucleotide) 
Spectrophotometry 325 342 
Spectrofluorimetry 420 420 
Spectrofluorimetry 1 0.09 
Spectrophotometry 1.9 X 106 
Equilibrium 
dialysis 2.0 × 106 
Spectrofluorimetry 1.9 × 106 
480 520 
610 600 
1 16 
1.18 X 106 
1.4 × 106 
1.55 × 106 
Spectrophotometry 0.22 0.20 
Equilibrium 
dialysis 0.22 0.20 
Spectrofluorimetry 0.22 0.20 
June 1982 
The binding isotherm (Scatchard plot) obtained 
from spectrophotometric and spectrofluorimetric 
titration data are shown in fig.4 and quantitative 
results on binding parameters are presented in table 1. 
Under the present experimental conditions, the 
binding ofethidium and sar/guinarine could be resolved 
into two components: one with high average intrinsic 
binding constant (kl); the other with a low intrinsic 
binding which was not ei/aluated ue to insufficient 
data. The present value of kl is in agreement with 
single binding constant for ethidium derived from 
absorbance [9] and fluorescence [5,10]. 
The melting temperatures (Tm) of calf thymus 
DNA (60/aM) in 0.1 THS buffer in absence and 
presence of sanguinarine (16 gM) were 6 8°C and 91 °C, 
respectively and that in presence of ethidium 
(16.5/aM) was 90.5°C. 
The viscosimetric titrations of sonicated calf 
thymus DNA (450/aM) were done by sanguinarine 
and ethidium. The experimental values for the ratio 
of the reduced viscosity of the complex (r/= r~sp[C, 
where r/sp is the specific viscosity) to that of native 
DNA 07o) when plotted against drug/DNA, showed a 
very steep rise and a saturation at drug/DNA = 0.3 
which remained unchanged up to the maximum 
drug/DNA value of ~43.50. The same ratio ~vhen 
plotted against r calculated experimentally from the 
measurements of spectrophotometric, spectrofluori- 
metric and equilibrium studies, showed linearity only 
up to r = 0.17. 
For confirmation of the monofunctional inter- 
calative mode of interaction between sanguinarine 
and DNA, the effect of sanguinarine treatment on 
viscosity of the sheared and rod-like DNA was studied. 
The increase of sheared DNA helix length upon inter- 
calation of sanguinarine can be calculated from the 
experimental results of the intrinsic viscosities accord- 
ing to the approximation [ 13 ]: 
L /L  o ~- (n/no) 11, = 1 + ~r 
where: 
L and L o = the contour lengths of the DNA in 
presence and absence of the drug, respec- 
tively; 
~/and rTo = the corresponding values of intrinsic 
viscosity (approximated by the reduced 
viscosity) of the solution; 
r = mol ligand bound/mol nucleotides; 
= the slope whenL/L o or (rl[~o) 1/3 is plotted 
against r. 
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Fig.5. Influence of sanguinarine (s) and ethidium (o) on the 
relative contour length of sheared rodqike calf thymus DNA. 
The ordinate represents the fractional increase inhelix length 
and abscissa shows the binding ratio (r). The theoretical lines 
( - - - )  represent a slope of 2, predicted for perfect mono- 
functional intercalators. 
The intercalating model of Lerman [14] predicts that 
for a perfect monofunctional nd a bifunctional inter- 
calator, the fl-value should be 2 and 4, respectively. 
As shown in fig.5 when (L/Lo) is plotted against r, 
the/3-values obtained from the slope were found to be 
1.66 for ethidium and 1.8 for sanguinarine. The 
/3-value for ethidium is in agreement with the experi- 
mental value of 1.79 [11] and 1.7 [12] reported for 
calf thymus DNA. 
The changes observed in the CD spectrum of DNA 
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Fig.6. CD spectra of calf thymus DNA (1), DNA-sanguinarine 
complex (2) and DNA-ethidium complex (3) in THS buffer; 
DNA was 240 tzM, sanguinarine 50.4 ~M and ethidium 48 uM. 
in presence of sanguinarine and ethidium are illus- 
trated in fig.6. The ethidium and sanguinarine both 
affect the CD spectrum of DNA in the same manner 
and cause large symmetrical increase in ellipticity of 
both major bands in the CD spectrum of DNA. Since 
neither the dye nor the alkaloid have an absorption 
band in this region, it would appear that these changes 
are the result of similar change in the DNA helical 
structure caused independently by both sanguinarine 
and ethidium. This suggests that the mode of sangui- 
narine binding to DNA is similar to the intercalative 
binding of ethidium with DNA. 
4.  D iscuss ion  
The strong interaction of sanguinarine with DNA 
was evident from the observation of the quenching 
effect of calf thymus DNA on the absorbance and 
fluorescence of sanguinarine and of the elevation of 
T m and also of the specific changes in viscosity of the 
sanguinarine treated DNA molecules. In addition to 
these changes anguinarine has been shown to alter 
the CD spectrum of DNA. This finding thus indicates 
that like ethidium the sanguinarine shows a strong 
interaction and is believed to involve intercalation of 
the alkaloid molecule into the adjacent basepair of 
the DNA [3]. 
The viscosimetric technique is well established as a 
method for investigating the extension of the DNA 
helix associated with intercalation [ 11-13,15,16]. 
The slope/~ in the L/L ovs r plot (fig.5) is a parameter 
related to the fractional increase in the contour 
length of the rod-like DNA molecule induced by 
intercalative agents. The intercalative model in [ 14] 
requires that the helix be extended by an amount 
equal to the thickness of a basepair (3.4,8,) for each 
intercalation event. If all bound drugs bind to DNA 
by intercalation, the ~-value should be 2 for mono- 
functional intercalator and 4 for bifunctional inter- 
calator. Here, the/3-value of sanguinarine (1.8) is very 
close to the theoretical value for monofunctional 
intercalator, suggesting a perfect monofunctional 
intercalation for linear od-like DNA molecules. More- 
over, preliminary studies indicate that sanguinarine 
inhibits the growth and macromolecular synthesis of 
Vibrio cholerae cells at a very low concentration 
(unpublished). However, the exact mode and mecha- 
nism of the anti-microbial nd anti-tumour action of 
sanguinarine are not known. 
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